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I SHOULD like to express first of all my appreciation of the honour which has
been paid to me by this invitation to deliver the Menary lecture.
I have chosen as the title of my lecture this afternoon the "Congenital
Haemolytic Anximias." Let me be honest and admit that this is a thin disguise for
a discussion of Cooley's Anamia, a condition in which I have been interested
for some years. This interest is not wholly academic. There are 45,000 Cypriots
living in London and at times I suspect that they are all living within half a mile
of mv Infant Welfare Clinic at The Middlesex Hospital and are regular attenders.
This interest in thalassxtmia has therefore rather been thrust upon nme.
It is approximately sixty years since the congenital hxnmolytic anxnmias were
first described clinically, but it is only within recent years, however, that we
have achieved some knowledge of the basic cell defects which are responsible
for the clinical manifestations of these diseases.
This afternoon I should like to discuss three of these congenital or constitutional
anaemias: hereditary spherocytosis or acholuric jaundice; sickle cell anamia or
drepanocvtic anaemia; and that strangely complex condition which is variously
called Cooley's anamia, thalassamia, or Mediterranean anxmia. My intention in
discussing the first two conditions is to try and use the knowledge which has
been acquired about their causation in an attempt to throw some light on the
basic defect in thalassxmia.
The constitutional hamolytic anxmias share many features in common but
vet retain certain individual characteristics. There is a marked hereditary factor
and often a strong racial tendency. The bone marrow shows marked hyperplasia,
and produces defective red cells, often of characteristic type. The survival of
the defective red cells is greatly reduced and the increased haemolysis causes
variable degrees of jaundice.
The investigation of these anxmias in the past has been based on the clinical
features, and the morphological changes seen in the peripheral blood. Family
studies have suggested stronglv that the diseases were genetically determined
but these studies have been difficult to interpret because of the infinite variations
in clinical pattern and behaviour seen in the three anxmias. In recent years the
recognition and exclusion of closely allied conditions have made these family
studies much easier to interpret.
During the past ten years the discovery of the abnornmal hxmoglobins has
afforded a valuable method for the further investigation of the constitutional
anamias. The existence of faetal hoemoglobin has been known for almost one
65hundred years and is sometimes called "resistant" hamoglobin because of the
difficulty with which it is denatured by strong alkali compared with adult
hxmoglobin. In the normal newborn infant over 80 per cent. of the hxmoglobin
is usuallv in the foetal form. After birth the A haemoglobin gene suppresses the
activity of the F gene and the percentage of F hamoglobin falls to about 50
per cent. at the age of three months. After this time the foetal hamoglobin
disappears rapidly although small amounts persist for many months or even
years. Opinions vary as to the level at which this foetal form may persist and
figures of from 1-2 per cent. are variously quoted. Higher percentages have
been found in patients suffering from haemolytic anaemias, leukxmia, aplastic and
pernicious anamia. Fcetal hemoglobin is a naturally occurring form and is not
an abnormal haemoglobin although it is usually only found in the young baby.
The development of electrophoretic techniques has shown that many other
hemoglobins may occur in anxmias of special type. Solutions of hxmoglobin
are prepared by the hamolysis of red cells and the removal of the cell envelopes
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FIG. 1.
The relativc electrophorctic mobilities of hxmoglobin solutions in barbiturate buffer at pH 8.6.
and other proteins. A drop of solution of hemoglobin is placed on a strip of
filter paper kept moist with a buffer solution to control the pH. An electric
current is passed along the paper and causes the hemoglobin molecules to migrate
towards the anode. Different h2moglobins migrate at different speeds and may
be separated and identified in this way. Figure 1 shows the different rates of
migration of different hamoglobins in veronal buffer at pH 8.6. The hamoglobins
are conventionally designated by the letters of the alphabet, A being the normal
adult form and F the fcetal, resistant form. Figure 2 shows strips which have
been run to identify some of the abnormal hxmoglobins. A hamoglobin has been
subdivided into A2 and A3 components. A3 moves further on the strip than A,
but is probably only a chemical variant. A2 is a slow moving component of this
group and is probably closely related to F haemoglobin. S henioglobin was first
discovered by Pauling in patients suffering from sickle cell anamia and C and D
hxmoglobins were found very soon afterwards. Since that time the alphabet is
rapidly being filled up with subsequent discoveries. Further separation of the
hemoglobins can be achieved by alteration in pH of the buffer solution or by
the use of starch gel or resin column chromatography. Perhaps we could leave
the significance of these hxemoglobins in clinical syndromes for later discussion.
I do not propose to deal with the clinical features of these anamias at any
length as I am sure that they are already well known to you.
66HEREDITARY SPHEROCYl-OSIS.
Hereditary spherocytosis or acholuric jaundice is a chronic familial anxmia
often of slight degree with a variable enlargement of the spleen. There is a mild
jaundice without bilirubin being present in the urine, and a great tendenicy to
acute crises of hxmolysis with the rapid development of a marked anxmia.
The clinical picture is very often not manifest in early childhood but occasion-
ally svmptoms are present during the earliest days of life. I have seen hxmolytic
crises as early as two months of age and splenectomy has been performed as
early as the seventeenth day of life. The condition must be borne in mind in
the differential diagnosis of neonatal jaundice, although it is not often discovered.
Between crises the general health is usually good with only a slight anxmia,
icterus and splenomegaly. The crises often appear to be precipitated by inter-
current infections and the child becomes feverish and ill; there is increased
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jaundice anid enlargement of the spleen; and the hoemoglobin falls rapidly because
of the increased hoemolysis. The degree of anxmias thus produced may be severe
and require blood transfusion, but the average case requires no specific therapy
and the stage of increased hoemolysis lasts onily a week or two.
The hx~matological findings are those of a mild anacimia with a colour index
near to unity but with the red cells showing miicrocystosis and spherocytosis.
The white cell count is within normal limits. The peripheral blood between crises
shows a constantly increased reticulocyte counit and after a hoemolytic crisis this
reticulocytosis may reach 50 per cent. or more, and miacrocytes appear in the
peripheral blood. The fragility of the erythrocytes in hypotonic saline is greatly
increased and this is very characteristic of the disease, although the finding may
be variable.
No abnormal hxmoglobin characteristic of the disease has yet been
demonstrated although fretal hxmoglobin is present in excess of normal levels.
67Family studies suggest that the transmission of hereditary spherocytosis is by
an incompletely or semi-dominant gene. Those who suffer from the disease are
probably heterozygous and the true homozygous state is not detectable clinically.
The spherocytes seen in the peripheral blood are thought to be the character-
istic cells of the disease and it is believed that they are the result of a defective
enzyme system in the cell. It is known that about one-third of the energy output
of the red cell is devoted to maintaining potassium in the cell and eliminating
sodium. The spherocyte shows potassium depletion and an upset of normal
glucose metabolism. There is a defect in the adenosine triphosphate enzyme
system in those erythrocytes and therefore a breakdown of the normal glucose
metabolism in the spherocyte. In conditions where there is a deficiency of glucose,
or competition for glucose, the abnormal cell suffers in comparison with the
normal cell, potassium depletion develops, and the cell "spheres" and is liable
to destruction. Such conditions are found in the spleen where the red cells
normally may be held for four to six hours in high concentration. The available
glucose level is low and hamolysis of the spherocytes occurs. For this reason
splenectomy in acholuric jaundice is curative in terms of the clinical symptoms
although it does nothing to alter the basic defect in the cells.
Acholuric jaundice is therefore a familial and genetically determined anxmia
in which the basic defect is probably in an enzyme system within the
erythrocytes, not all of whom are affected.
SICKLE CELL ANAEMIA OR DREPANOCYTIC ANIEMIA.
This anaemia was first described by Herrick in 1910 and the clinical reports
have almost entirely been derived from negro populations. The an:mia shows
the constitutional, racial and familial features of the congenital anmmias. The
diagnostic feature is the sickling of the red cells. Some individuals suffer from
the sickle trait and show the characteristic haematological features of the disease
but suffer little from anxmia or from crises of haemolysis. They are said to carry
the trait or suffer from sicklemia. The full-blown disease-sickle cell anaemia-
is seen more commonly in children than in adults. Patients show progressive
or severe anemia, haemolytic crises and marked splenomegaly with moderate
jaundice. During the crises there is often joint, limb, or abdominal pain and
fever. There is increased jaundice and splenomegaly and the anxmia may become
profound. The pains are thought to be due to clumping of the abnormal cells
in the vessels. Leg ulcers are not uncommon. The hamatological findings between
crises are those of definite anaemia, considerable variation in the size and shape
of the red cells with some target forms and macrocytes, and a significant
leucocytosis. There is considerable marrow hyperplasia. The typical sickle cell
is not seen on examination of the ordinary blood smear but only in wet-drop
preparations under conditions of cooling and anoxia, or if the hamoglobin is
reduced by sodium metabisulphite when the erythrocytes assume a sickle or
holly leaf form, This characteristic is also present in individuals who carry the
trait (Fig. 3, P1. I). The fragility of the red cells is not characteristically altered.
X-ray of the skeleton may show the changes of marrow hyperplasia.
68The sickle trait is said to occur in 5-10 per cent. of North American negroes,
but in Africa this proportion varies widely from tribe to tribe, the trait being
present in 45 per cent. of some communities. In North American negroes about
one in forty of the individuals carrying the trait shows the clinical picture of
sickle cell anxmia. In 1949 Neel showed that the condition is genetically de-
termined, the S gene being an allele of the A gene. The heterozygous carrier of
the gene shows sicklaxmia and it is only in the homozygous carrier that the full-
blown picture of the sickle cell anaemia develops. In the same year Pauling
demonstrated that the abnormal hamoglobin S is the outward manifestation of
this genetic abnormality. In the heterozygote S haemoglobin is present to the
extent of about 22-45 per cent. with the remainder of the haemoglobin as A
but in true sickle cell anxmia the patient who is homozygous for the gene shows
80-98 per cent. hxmoglobin S and the remainder 2-20 per cent. F haemoglobin.
The amount of S hoemoglobin varies from one individual to another, but remains
constant for the individual.
The reduced form of S hxmoglobin is much less soluble than the oxygenated
form and under conditions of anoxia the h;emoglobin goes into a filamentous
gel form. It is this "gelling" which produces the sickle or holly leaf form of
the cell and renders them liable to haemolysis. The sickling occurs intravascularly
under conditions where anoxia or stasis occurs and this is probably the cause
of the crises of pain which occur in the disease. The hemolytic crises are often
aplastic crises where the marrow ceases to produce cells, normal or abnormal.
Thus sickle cell anamia is a disease due to a genetically transmitted defect in
hemoglobin formation and the abnormal characteristics of the hzemoglobin in
turn produce the clinical manifestations of the disease.
THALASSEMIA.
Thalass-xmia, in contrast to the two previous an:emias, is less easy to fit into
a definite atiological group.
Thalassaemia or Mediterranean anxmia was first described in 1921 by Cooley
and the anxmia is often called by this name, despite Cooley's attempts to reject
the title. At first it was thought that the disease was confined to individuals from
the countries on the north shore of the Mediterranean. However, there have
been many reports of the anxmia, or a closely allied anemia, from India and
other Eastern countries and from other parts of Europe, including the United
Kingdom.
The congenital and familial aspects of the disease have been well established.
Patients can be found who carry the trait and are said to suffer from thalassmemia
minor. In contrast thalassemia major is more commonly seen in young children
than adults and they suffer from marked symptoms. Attempts have been made
to establish other clinical subdivisions of the syndrome such as thalassxmia
minima and thalassxmia intermedia, but these probably represent other genetic
variants, and are conditions closely allied to thalass:emia but genetically different.
Thalassemia minor shows a constant mild anxmia of the hypochromic type
in which a lack of full hemoglobinisation is compensated by high red cell counts,
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Falthough the tvpical haematological abnormalities are seen in the blood. Good
general health may be enjoyed by these individuals.
Thalassamia major is more usually seen in young children in whom a
progressive anaemia develops with splenomegaly of quite marked degree. The
anxmia and splenomegaly may develop in the early weeks of life and the earlier
the symptoms appear the more rapid is the deterioration. We have seen the
condition suspected at the age of three weeks and fully established by the sixth
week of life. Hamolytic crises are much less evident than in sickle cell anaemia
although intercurrent infections seem to accelerate the rate of fall in the red
cell count.
In established cases there is a muddy pallor of the complexion and the veins
are abnormally visible. The liver and the spleen are considerably enlarged and
are firm. These patients develop a characteristic facies which is described as
Mongoloid and it has been said that they more closely resemble each other than
they resemble their unaffected brothers and sisters (Figs. 4 and 5, P1. II). The
anxamia is progressive although the rate of progression varies widely from case
to case, but few of the patients with severe symptoms live beyond the tenth year.
In less severely affected patients the disease appears to slow its progression once
the patients pass the age of ten. Death is usually from heart failure caused by
the anxmia although intercurrent infections are also important. Hrmosiderosis
is comnmon and may partly be due to the repeated transfusions.
Hrematological findings. The red cells show a marked hypochromia and the
colour index is low, often 0.6. This feature is in marked distinction to the two
other anamias we have discussed. The red cells (Fig. 6, P1. I) show marked
variationi in size and shape and large numbers of macrocytes are seen, large, thin,
pancake-like cells poorly filled with haemoglobin and distorted into the target
or Mexican hat forms. There are large numbers of fragmented cells in the
peripheral blood, and this, together with the high nucleated red cell count,
shows the marked degree of red cell destruction which is occurring. The serum
is usually definitely icteric. There serum iron is high (ofteni 400 1e) and the
iron binding capacity of the serum protein is low. The erythrocyte fragility in
hypotonic saline is reduced and the fragility curve is on a wide base. This
together with the hypochromic anrmia is characteristic.
There is marked extramedullary hrmatopoiesis and after some time the skeletal
X-rays give evidence of this. The marrow spaces are wide and trabeculation is
seen. In the skull there may be marked spiculation over the vertex (Fig. 7,
P1. II1).
There is no treatment for the disease other than symptomatic. Although the
disease is a hypochromic anxmia, iron therapy does nothing to slow the in-
evitable progression of the anoemia, or to lengthen the interval between the
transfusions which become necessarv to maintain life. The inherent defect in
hoemoglobin synthesis prevents the use of the available iron. This patient is really
living on transfused blood. The place of splenectomy in the disease has been
the subject of controversy. In hereditary spherocytosis the cell destruction takes
place largely in the spleen and splenectomy effects a clinical cure. In thalassxmia
70the destruction of the abnormal red cells takes place elsewhere and may indeed
take place in the marrow at the time of their formation. We had noticed the
conisiderable variation in the size of the spleen before, during and after transfusion
in some of the more severe cases requiring transfusion at intervals of a few weeks.
This suggested that the spleen might be showing a secondary hypersplenism and
negativing the benefit of the transfusions. We have carried out splenectomy in
four cases, but, as the slides show, without any convincing evidence that
splenectomy has greatly lessened the frequency of need for transfusion (Fig. 8).
There is, however, some evidence that splenectomy may be beneficial to some
degree.
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FIG. 8.
Showing rcsponse in thalassxmia to transfusioni before and after splenectomy.
It is our impression that the treatment of any chronic focus of infection is
of great benefit and in one case tonsillectomy seemed to confer a greater benefit
than subsequently did removal of the spleen.
These patients require frequent transfusions and, especially in the younger
children, this may create a great technical difficultv over veins. Intraperitoneal
transfusion offers great advantages in this type of case. We have had an oppor-
tunity of seeing the peritoneal cavity of a child one week after an intraperitoneal
transfusion of blood in an amount equal to one-third of the blood volume. At
operation the peritoneum looked normal and all the blood had been absorbed.
We have transfused blood intraperitoneally on ten occasions in one case, and
on eighteen occasions in another patient. Absorption of the transfused blood
continues satisfactorily in successive transfusions.
The prognosis in these cases without transfusion is very grave and if tranfusion
is required in the first two years of life the prognosis is virtually hopeless. In
general, there appears to be an optimum hTmoglobin level at which these patients
remain comfortable but above which the hamoglobin level cannot long be
retained. It is useless to transfuse above this level. Although it is believed that
thalassaemia is genetically transmitted and that thalassoemia minor represents the
heterozygote and thalassxemia major the homozygous carrier of the gene, the
inheritance is not so clearly defined as in sickle cell anamia. This slide shows
71the familial nature of the anamia (Fig. 9, P1. IV). No characteristic abnormal
hzmoglobin has been demonstrated although thalassoemia major patients have up
to 80 per cent. of their haemoglobin in the foetal, alkali resistant form. One of
our cases of thalassaemia in a Persian boy aged 15 produced 79 per cent. F,
12 per cent. A2 and only 9 per cent. of normal adult A hamoglobin. Thalassmmia
intermedia and minima do not fit well with this conception of transmission by
a recessive gene, unless it is one with a very variable expression or unless there
are several variants of the thalassormia gene. The latter theory seems not im-
probable. In thalassemia there is no special h2emoglobin which differentiates the
condition from closely allied states. The presence of high percentages of
hemoglobin A2 marks out some cases of thalassaemia from the rest.
Wide clinical variations are seen in the combination of the thalassoemia gene
with other genes responsible for the production of abnormal hemoglobins.
Individuals who are heterozygous for h2moglobin S or C, when simultaneously
heterozygous for the thalassxmia gene, produce a clinical syndrome which is
different from the picture seen with either of the genes separately or the
homozygous state of either gene.
This combination of two genes, each inherited independently in the heterozy-
gous state, sometimes produces much larger amounts of the abnormal hemoglobin
than in the heterozygote-so-called "interacting" thalassamia. In thalassxmia-S
anicmia the proportion of S hamoglobin may be about 70 per cent. instead of
the 30-40 per cent. usually seen in sicklxmia. This enhancement of the production
of the abnormal hemoglobin by the thalassoemia gene is not invariable and,
together with the high level of A2 in the homozygote, is a useful differentation
between "true" thalassemia and closely similar conditions.
Another point of interest is the poor haemoglobinisation which occurs even
in the presence of high levels of serum iron.
The failure of real benefit from splenectomy suggests that the anamia is due
to a central defect and not to a peripheral destruction.
It has been suggested that in thalassxemia there is a marked destruction of red
cells in the marrow at the time of formation as if the cells were too defective
ever to reach the circulation. Alternatively, it has been suggested that the defect
is a failure or inhibition of the A gene. 'The production of F or A2 haemoglobin
is, therefore, a compensatory mechanism to h;moglobinize the cells with a less
efficient substitute. In thalass-xmia-S syndromes the enhancement of production
of S hzmoglobin suggests that this is easier to produce than F. Whichever of
these reasons is the true one, it would appear that the basic defect in thalassxmia
is genetically determined and that a defective cell is produced, the defect
probably being in hemoglobin synthesis without the production of a specific
abnormal hemoglobin.
These three anamias, which show closely similar clinical syndromes, represent
three distinct modes of production of red cells.
Much of what I have said remains speculative but I hope that it has not been
too tedious for you to wander with me in the realms of speculation.
I wish to thank the Photographic Department of the Middlesex Hospital for the illustrations.
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FIG. 3.
Blood film in sickle-cell anxmia.
FIG. 6.
Blood film in thalassomia showing target cells.
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Fi(;. 4.
Facics and enlargement of spleen
and liver in thalassxmia.
FIG. 5.
Facies in thalassxmia.
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FIG. 7.
Skull in thalassxrnia.
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FIG. 9.
The familial inheritance of sickle-cell anamia.
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